BioCentury
ARTICLE | Clinical News

B-701: Phase II started

October 5, 2015 7:00 AM UTC

BioClin began a double-blind, placebo-controlled, U.S. Phase II trial to compare 25 mg/kg IV B-701 with docetaxel on day 1 of each 21-day cycle vs. docetaxel alone in about 211 patients with stage IV ...